Læknaneminn - 01.10.1991, Qupperneq 76

5. Schneerson R, Barrera O, Sutton A, Robbins JB.
Preparation, characterization and immunogenicity of
Haemophilus influenzae b polysaccharide-protein
conjugates. J ExpMed 152: 361-376, 1980.
6. Granoff DM, Boies EG, Munson RS. Immunogenicity of
Haemophilus influenzae type b polysaccharide-diphtheria
toxoid conjugate vaccine in adults. J Pediatr 105: 22-27,
1984.
7. Lepow ML, Samuelson JS, Gordon LK. Safety and
immunogenicity of Haemophilus influenzae type b-
polysaccharide diphtheria toxoid conjugate vaccine in
infants 9-15 months of age. J Pediatr 106:185-189, 1985.
8. Eskola J, Peltola H, Takala AK, et al. Efficacy of
Haemophilus influenzae type b polysaccharide- diphtheria
toxoid conjugate vaccine in infancy. New Engl J Med. 317:
717-722, 1987.
9. Ward JI, Brenneman G, Letson G et al. Limited protecti ve
efficacy of an H. influenzae type b conjugate vaccine (PRP-
D) in native Alaskan infants. New Engl J Med 323: 1393-
1400, 1990
10. Ward J. Prevention ofinvasiveHaemophilus influenzae
type b disease: lessons from vaccine efficacy trials. Vaccine
9: Supplement: 17-24, June 1991.
11. Peltola H, Eskola H, Kaythy A et al. Protective efficacy
of the HbOC and PRP-D Haemophilus influenzae type b
conjugate vaccines when given at 4,6 and 14 to 18 months
of age (abstract). Pediatr Res 27: 179A, 1990.
12. Black SS, Shinefield HR, Fireman B et al. Efficacy in
infancy of oligosaccharide conjugate Haemophilus
influenzae type b (HbOC) vaccine in a United States
population of 61.080children. Pediatrlnf Dis J 10: 97-104,
1991.
13. Lenoir AA, Granoff PD, Granoff DM. Immunogenicity
of Haemophilus influenzae Type b Polysaccharide-
NeisseriaMeningitidisOuterMembraneProteinConjugate
Vaccine in 2 to 6-Month-Old Infants. Pediatrics 80: 283-
287, 1987.
14. Santosham M, Wolff M, Reid R et al. The efficacy in
Navajo infants of a conjugate vaccine consisting of
Haemophilus influezae type b polysaccharide and Neisseria
meningitidis outer-membrane protein complex. New Engl J
Med 324: 1767-1772, 1991.
15. Claesson BA, Schneerson R, Lagergárd T et al.
Persistence of serum antibodies elicited by Haemophilus
influenzae type b-tetanus toxoid conjugate vaccine in
infants vaccinated at 3,5 and 12 months of age. Pediatr inf
DisJ 10:560-564, 1991.
Kristín E. Jónsdóttir
LATUM
IFRIÐI
Hendum ekki sígarettustubbum
eða flöskubrotum á víðavangi.
ATV?